FLAM
First Light Asset Management Portfolio holdings
AUM
$771M
This Quarter Return
+26.26%
1 Year Return
+33.17%
3 Year Return
+208.13%
5 Year Return
+426.73%
10 Year Return
+3,318.8%
AUM
$976M
AUM Growth
+$976M
(+14%)
Cap. Flow
-$7.28M
Cap. Flow
% of AUM
-0.75%
Top 10 Holdings %
Top 10 Hldgs %
57.9%
Holding
70
New
10
Increased
18
Reduced
14
Closed
10
Top Buys
| 1 |
Omnicell
OMCL
|
$31.4M |
| 2 |
CareDx
CDNA
|
$21.1M |
| 3 |
Axogen
AXGN
|
$20.1M |
| 4 |
Arrowhead Research
ARWR
|
$12.5M |
| 5 |
Halozyme
HALO
|
$11.8M |
Top Sells
| 1 |
PFNX
Pfenex Inc.
PFNX
|
$19.6M |
| 2 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$18.6M |
| 3 |
United Therapeutics
UTHR
|
$15.5M |
| 4 |
Zymeworks
ZYME
|
$13.1M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
$12.7M |
Sector Composition
| 1 | Healthcare | 72.21% |
| 2 | Communication Services | 3.37% |
| 3 | Energy | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $134M | 13.75% | 1,577,880 -90,860 | -5% | -$7.73M |
|
|
SPNE
2
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $73M | 7.48% | 5,105,237 -7,673 | -0.2% | -$110K |
|
|
3
CareDx
CDNA
$727M
| $71.7M | 7.35% | 1,890,213 +557,275 | +42% | +$21.1M |
|
|
OXFD
4
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $54.3M | 5.56% | 4,639,199 +13,997 | +0.3% | +$164K |
|
5
KORU Medical Systems
KRMD
$195M
| $52.4M | 5.37% | 7,257,266 -274,884 | -4% | -$1.98M |
|
|
6
Halozyme
HALO
$8.56B
| $50.1M | 5.13% | 1,906,789 +448,244 | +31% | +$11.8M |
|
7
Insmed
INSM
$28.8B
| $33M | 3.38% | 1,025,341 +903 | +0.1% | +$29K |
|
|
MODN
8
DELISTED
MODEL N, INC.
MODN
| $32.9M | 3.37% | 931,967 -6,321 | -0.7% | -$223K |
|
9
Glaukos
GKOS
$5.5B
| $32.2M | 3.3% | 650,289 -732 | -0.1% | -$36.2K |
|
|
10
Omnicell
OMCL
$1.5B
| $31.4M | 3.22% | +420,354 | New | +$31.4M |
|
11
Tandem Diabetes Care
TNDM
$845M
| $29.2M | 2.99% | 257,205 -23,145 | -8% | -$2.63M |
|
12
Y-mAbs Therapeutics
YMAB
$388M
| $23.3M | 2.39% | 608,193 +572 | +0.1% | +$22K |
|
13
NeoGenomics
NEO
$1.13B
| $22.6M | 2.32% | 613,102 +420 | +0.1% | +$15.5K |
|
14
AtriCure
ATRC
$1.84B
| $22.4M | 2.29% | 561,018 +21,256 | +4% | +$848K |
|
15
Genmab
GMAB
$15.3B
| $22.1M | 2.27% | 603,870 +7,496 | +1% | +$274K |
|
|
16
Axogen
AXGN
$743M
| $20.1M | 2.06% | +1,729,435 | New | +$20.1M |
|
17
Krystal Biotech
KRYS
$4.27B
| $20M | 2.05% | 464,663 +484 | +0.1% | +$20.8K |
|
|
ARNA
18
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $19.8M | 2.03% | 265,339 +249 | +0.1% | +$18.6K |
|
|
XENT
19
DELISTED
Intersect ENT, Inc
XENT
| $19.4M | 1.99% | 1,188,534 +1,084 | +0.1% | +$17.7K |
|
20
Teva Pharmaceuticals
TEVA
$21.1B
| $16.8M | 1.72% | 1,860,025 -224,078 | -11% | -$2.02M |
|
21
SI-BONE Inc
SIBN
$719M
| $15.9M | 1.63% | 669,120 -340 | -0.1% | -$8.07K |
|
22
Ultragenyx Pharmaceutical
RARE
$2.89B
| $15.2M | 1.56% | 184,970 -51,988 | -22% | -$4.27M |
|
|
23
Arrowhead Research
ARWR
$3.05B
| $12.5M | 1.28% | +290,487 | New | +$12.5M |
|
24
QuidelOrtho
QDEL
$1.95B
| $12.4M | 1.28% | 56,728 +17,380 | +44% | +$3.81M |
|
25
OptimizeRx
OPRX
$335M
| $12.3M | 1.26% | 590,000 | – | – |
|